biotech tirzepatide UPB Tirz 30MG (Double Agonist) Lose up to 20% of your body weight with this simple Richards Biotech Simply Richards: Tirzepatide

You cannot do 0.375mg

However, individuals with a medical or family history of thyroid cancer or those with multiple endocrine neoplasia syndrome type 2 (MEN2) should exercise caution, as GLP-1 is not recommended for this demographic

Once approved by a provider, the prescription is sent to a compounding pharmacy for preparation

Another oral option, Foundayo (orforglipron), was FDA-approved in April 2026 and is in MHRA review

The dosage is determined by a healthcare professional, starting with a lower dose and gradually adjusting to achieve the desired effect

This article reviews current evidence on GLP-1 therapies and CKD progression, including biomarker data, clinical trial findings, and the potential role of these agents within evolving kidney disease treatment strategies